Marketed in 54 countries across Europe, the Americas, Asia, and Oceania, Tegretol is a globally distributed brand of carbamazepine, classified primarily as an anticonvulsant and antiepileptic agent with additional analgesic and mood-stabilising roles. For an international reader trying to identify the same medication abroad, this footprint means Tegretol is one of the more recognisable carbamazepine-containing brands a traveller or expatriate is likely to encounter.
Carbamazepine is prescribed in the management of epilepsy, including partial seizures, and in trigeminal neuralgia and other neuralgic pain. It is also indicated in certain psychiatric contexts, including some forms of psychosis and depressive psychosis, where its profile as a mood stabiliser is relevant. The complete list of registered uses recognised across the markets where Tegretol is sold appears in the structured indication section further down this page.
Because Tegretol is so widely registered, patients moving between countries often find the same brand on the shelf — though regulatory status, available formulations, and packaging vary considerably from one market to another. Representative countries where Tegretol is registered include Brazil, Australia, Egypt, Canada, and China. In some of these markets carbamazepine also circulates as a generic or under alternative brand names, and a local pharmacist can clarify what is available domestically.
Other medications in the broader anticonvulsant and antiepileptic class are sold internationally under different molecules, but antiepileptic therapy is closely individualised and substitution is not a self-service decision. Anyone taking Tegretol, considering it, or trying to identify an equivalent abroad should keep that decision with a healthcare provider familiar with the patient's history.
Shelf life
Three years
Incompatibilities
None known
List of excipients
Polyethylene glycol 400 stearate, cellulose, microcrystalline, sorbitol solution 70%, saccharin sodium, hydroxyethyl cellulose, methyl hydroxybenzoate, propyl hydroxybenzoate, sorbic acid, propylene glycol, caramel flavour 52.929A (E150), purified water.
Date of revision of the text
04 January 2018
Marketing authorisation holder
Novartis Pharmaceuticals UK Limited
Trading as Geigy Pharmaceuticals
Frimley Business Park
Frimley
Camberley
Surrey
GU16 7SR
England.
Special precautions for storage
Do not store above 30°C.
Keep the bottle tightly closed.
Keep bottle in the outer carton in order to protect from light.
Nature and contents of container
Tegretol Liquid comes in a 300ml amber glass bottle with either a conventional cap, child resistant/tamper evident cap, tamper evident cap or child resistant cap.
Marketing authorisation number(s)
PL 00101/0456
Special precautions for disposal and other handling
None
Date of first authorisation/renewal of the authorisation
4 July 1997 / 5 December 2008
